aTyr Pharma | LIFE - Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
Ardelyx USD 5.6M 160K 2026-03
aTyr Pharma 79.65M 78.89M 2026-03
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 411M 21M 2026-03
Cipla INR 131.3M 9M 2026-03
Compugen USD 1.35M 399K 2026-03
CSL USD 215M 111M 2025-12
Curis USD 178K 441K 2023-12
GlaxoSmithKline GBP 167M 21M 2026-03
Grifols EUR 156.07M 31.46M 2025-09
Lakefront Biotherapeutics EUR 1.72M 940K 2025-09
Novartis USD 343M 39M 2026-03
Roche Holding CHF 304M 7.5M 2025-06
United Therapeutics USD 3.1M 100K 2025-12
Xoma USD 3.4M 150K 2024-06